Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:2713-2722, 2006
DOI: 10.2337/db05-1430
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maedler, K.
Right arrow Articles by Donath, M. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maedler, K.
Right arrow Articles by Donath, M. Y.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Low Concentration of Interleukin-1ß Induces FLICE-Inhibitory Protein–Mediated ß-Cell Proliferation in Human Pancreatic Islets

Kathrin Maedler1, Desiree M. Schumann2, Nadine Sauter2, Helga Ellingsgaard2, Domenico Bosco3, Reto Baertschiger3, Yoichiro Iwakura4, José Oberholzer5, Claes B. Wollheim6, Benoit R. Gauthier6, and Marc Y. Donath2

1 Larry L. Hillblom Islet Research Center, University of California, Los Angeles, California
2 Division of Endocrinology and Diabetes and Center for Integrative Human Physiology, University Hospital Zurich, Zurich, Switzerland
3 Department of Surgery, University Medical Center, Geneva, Switzerland
4 Center for Experimental Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan
5 Division of Transplantation, University of Illinois at Chicago, Chicago, Illinois
6 Department of Cell Physiology and Metabolism, University Medical Center, Geneva, Switzerland

Address correspondence and reprint requests to Marc Y. Donath, MD, Division of Endocrinology and Diabetes, Department of Medicine, University Hospital, CH-8091 Zurich, Switzerland. E-mail: marc.donath{at}usz.ch

Abbreviations: FLIP, FLICE-inhibitory protein; GSIS, glucose-stimulated insulin secretion; IL, interleukin; IL-1Ra, IL-1 receptor antagonist; IRS, insulin receptor substrate; KRBB, Krebs-Ringer bicarbonate buffer; PDX, pancreatic duodenal homeobox; rh, recombinant human; siFLIP, siRNA directed to FLIP; siIL-1Ra, siRNA directed to IL-1Ra; siRNA, small interfering RNA; TUNEL, transferase-mediated dUTP nick-end labeling

High glucose concentrations have a dual effect on ß-cell turnover, inducing proliferation in the short-term and apoptosis in the long-term. Hyperglycemia leads to ß-cell production of interleuking (IL)-1ß in human pancreatic islets. Fas, a death receptor regulated by IL-1ß, is involved in glucose-induced ß-cell apoptosis. Fas engagement can be switched from death signal to induction of proliferation when the caspase 8 inhibitor, FLICE-inhibitory protein (FLIP), is active. Here, we show that IL-1ß at low concentrations may participate in the mitogenic actions of glucose through the Fas-FLIP pathway. Thus, exposure of human islets to low IL-1ß concentrations (0.01–0.02 ng/ml) stimulated proliferation and decreased apoptosis, whereas increasing amounts of IL-1ß (2–5 ng/ml) had the reverse effects. A similarly bimodal induction of FLIP, pancreatic duodenal homeobox (PDX)-1, and Pax4 mRNA expression, as well as glucose-stimulated insulin secretion, was observed. In contrast, Fas induction by IL-1ß was monophasic. Low IL-1ß also induced the IL-1 receptor antagonist (IL-1Ra), suppression of which by RNA interference abrogated the beneficial effects of low IL-1ß. The Fas antagonistic antibody ZB4 and small interfering RNA to FLIP prevented low IL-1ß–stimulated ß-cell proliferation. Consistent with our in vitro results, IL-1ß knockout mice displayed glucose intolerance along with a decrease in islet Fas, FLIP, Pax4, and PDX-1 transcripts. These findings indicate that low IL-1ß levels positively influence ß-cell function and turnover through the Fas-FLIP pathway and that IL-1Ra production prevents harmful effects of high IL-1ß concentrations.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
L. Shu, N. S. Sauter, F. T. Schulthess, A. V. Matveyenko, J. Oberholzer, and K. Maedler
Transcription Factor 7-Like 2 Regulates {beta}-Cell Survival and Function in Human Pancreatic Islets
Diabetes, March 1, 2008; 57(3): 645 - 653.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Ribaux, J. A. Ehses, N. Lin-Marq, F. Carrozzino, M. Boni-Schnetzler, E. Hammar, J.-C. Irminger, M. Y. Donath, and P. A. Halban
Induction of CXCL1 by Extracellular Matrix and Autocrine Enhancement by Interleukin-1 in Rat Pancreatic {beta}-Cells
Endocrinology, November 1, 2007; 148(11): 5582 - 5590.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. M. Schumann, K. Maedler, I. Franklin, D. Konrad, J. Storling, M. Boni-Schnetzler, A. Gjinovci, M. O. Kurrer, B. R. Gauthier, D. Bosco, et al.
The Fas pathway is involved in pancreatic beta cell secretory function
PNAS, February 20, 2007; 104(8): 2861 - 2866.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.